ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
+37.46%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$213M
AUM Growth
+$213M
(+11%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-5.04%
Top 10 Holdings %
Top 10 Hldgs %
62.62%
Holding
43
New
2
Increased
12
Reduced
15
Closed
6
Top Buys
| 1 |
nLIGHT
LASR
|
$11.8M |
| 2 |
Domo
DOMO
|
$8.24M |
| 3 |
Allient
ALNT
|
$7.26M |
| 4 |
Vishay Precision Group
VPG
|
$4.49M |
| 5 |
Myomo
MYO
|
$1.4M |
Top Sells
| 1 |
BK Technologies
BKTI
|
$10.5M |
| 2 |
Intellicheck
IDN
|
$7.78M |
| 3 |
Akebia Therapeutics
AKBA
|
$5.62M |
| 4 |
Zevra Therapeutics
ZVRA
|
$4.57M |
| 5 |
Delcath Systems
DCTH
|
$3.32M |
Sector Composition
| 1 | Healthcare | 53.41% |
| 2 | Technology | 35.03% |
| 3 | Industrials | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$434M
| $24.4M | 10.99% | 3,723,958 -244,990 | -6% | -$1.61M |
|
|
2
Domo
DOMO
$591M
| $18.7M | 8.43% | 1,341,518 +589,935 | +78% | +$8.24M |
|
3
scPharmaceuticals
SCPH
$295M
| $14.7M | 6.63% | 3,867,523 -228,844 | -6% | -$872K |
|
4
Arq
ARQ
$330M
| $14.3M | 6.41% | 2,654,486 -115,792 | -4% | -$622K |
|
|
5
Vishay Precision Group
VPG
$377M
| $11.9M | 5.35% | 423,484 +159,919 | +61% | +$4.49M |
|
|
6
nLIGHT
LASR
$1.44B
| $11.8M | 5.31% | +600,103 | New | +$11.8M |
|
7
Lightpath Technologies
LPTH
$230M
| $11.2M | 5.05% | 3,642,377 -40,555 | -1% | -$125K |
|
8
Backblaze
BLZE
$471M
| $9.95M | 4.48% | 1,809,096 +96,775 | +6% | +$532K |
|
9
Verastem
VSTM
$569M
| $8.31M | 3.74% | 2,003,179 -334,575 | -14% | -$1.39M |
|
|
10
Zevra Therapeutics
ZVRA
$509M
| $8.1M | 3.64% | 918,893 -519,216 | -36% | -$4.57M |
|
|
11
Myomo
MYO
$39.7M
| $7.68M | 3.45% | 3,555,742 +649,053 | +22% | +$1.4M |
|
|
ELVA
12
Electrovaya
ELVA
$243M
| $7.35M | 3.31% | 2,155,836 -106,487 | -5% | -$363K |
|
|
13
Allient
ALNT
$769M
| $7.26M | 3.27% | +200,000 | New | +$7.26M |
|
14
Elutia
ELUT
$96.7M
| $6.83M | 3.07% | 3,451,025 +69,610 | +2% | +$138K |
|
15
Coya Therapeutics
COYA
$110M
| $6.36M | 2.86% | 1,105,622 -78,158 | -7% | -$449K |
|
16
Heron Therapeutics
HRTX
$207M
| $6.23M | 2.8% | 3,009,257 +231,057 | +8% | +$478K |
|
|
THTX
17
Theratechnologies
THTX
$149M
| $4.91M | 2.21% | 2,082,491 -244,078 | -10% | -$576K |
|
18
AngioDynamics
ANGO
$417M
| $4.71M | 2.12% | 474,488 | – | – |
|
19
RenovoRx
RNXT
$35.2M
| $4.56M | 2.05% | 3,467,275 | – | – |
|
20
PolyPid
PYPD
$53.3M
| $4.22M | 1.9% | 1,194,108 +253,727 | +27% | +$896K |
|
21
Fennec Pharmaceuticals
FENC
$247M
| $3.75M | 1.69% | 452,400 +91,395 | +25% | +$759K |
|
|
GRCE
22
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $3.35M | 1.51% | 1,128,497 -193,882 | -15% | -$576K |
|
23
Ideal Power
IPWR
$44.5M
| $3.03M | 1.36% | 668,623 -149,692 | -18% | -$678K |
|
24
AmpliTech
AMPG
$78.2M
| $1.92M | 0.86% | 905,453 | – | – |
|
25
KALA BIO
KALA
$78.8M
| $1.43M | 0.64% | 300,000 +103,650 | +53% | +$493K |
|